![Barbara Kahlke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barbara Kahlke
Direttore/Membro del Consiglio presso tiakis BIOTECH AG
Profilo
Barbara Kahlke is a Member-Supervisory Board at tiakis BIOTECH AG since 2000.
She was a Secretary & Director at Proteo, Inc. from 2011 to 2012.
Dr. Kahlke holds a doctorate degree from the University of Kiel.
Posizioni attive di Barbara Kahlke
Società | Posizione | Inizio |
---|---|---|
tiakis BIOTECH AG
![]() tiakis BIOTECH AG BiotechnologyHealth Technology Tiakis BIOTECH AG is a German company that operates as a next generation tissue protective therapeutic technology company. The company is based in Kiel, Germany. Tiakis BIOTECH AG was founded in 2000 by Oliver Wiedow. | Direttore/Membro del Consiglio | 01/05/2000 |
Precedenti posizioni note di Barbara Kahlke
Società | Posizione | Fine |
---|---|---|
PROTEO, INC. | Direttore/Membro del Consiglio | 23/05/2012 |
Formazione di Barbara Kahlke
University of Kiel | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Proteo, Inc.
![]() Proteo, Inc. Pharmaceuticals: MajorHealth Technology Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The firm focuses on the development of anti-inflammatory treatments for rare diseases. Its proprietary product Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands. The company's product is intended for the treatment of post-surgery damage to tissue, pulmonary hypertension, serious injuries caused by accidents, cardiac infarction, and other diseases, as well as for the complications resulting from organ transplantation. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA. | Health Technology |
tiakis BIOTECH AG
![]() tiakis BIOTECH AG BiotechnologyHealth Technology Tiakis BIOTECH AG is a German company that operates as a next generation tissue protective therapeutic technology company. The company is based in Kiel, Germany. Tiakis BIOTECH AG was founded in 2000 by Oliver Wiedow. | Health Technology |
- Borsa valori
- Insiders
- Barbara Kahlke